Contrasting Glass House Brands (OTCMKTS:GLASF) & Achieve Life Sciences (NASDAQ:ACHV)

Achieve Life Sciences (NASDAQ:ACHV) and Glass House Brands (OTCMKTS:GLASF) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Profitability

This table compares Achieve Life Sciences and Glass House Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Achieve Life Sciences	N/A	-511.12%	-82.35%
Glass House Brands	N/A	N/A	N/A

Valuation & Earnings

This table compares Achieve Life Sciences and Glass House Brands”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Achieve Life Sciences	N/A	N/A	-$54.65 million	($1.55)	-5.23
Glass House Brands	N/A	N/A	N/A	N/A	N/A

Insider & Institutional Ownership

33.5% of Achieve Life Sciences shares are held by institutional investors. 1.8% of Achieve Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Achieve Life Sciences and Glass House Brands, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Achieve Life Sciences	1	0	5	2	3.00
Glass House Brands	0	1	0	0	2.00

Achieve Life Sciences presently has a consensus target price of $15.00, indicating a potential upside of 85.19%. Given Achieve Life Sciences’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Achieve Life Sciences is more favorable than Glass House Brands.

Summary

Achieve Life Sciences beats Glass House Brands on 6 of the 8 factors compared between the two stocks.

About Achieve Life Sciences

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

About Glass House Brands

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.